We are live on ! Find out more
NXTC icon

NextCure
NXTC

38 hedge funds and large institutions have $7.38M invested in NextCure in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 9

0.2% less ownership

Funds ownership: 4.77% → 4.57% (-0.2%)

16% less funds holding

Funds holding: 45 → 38 (-7)

44% less capital invested

Capital invested by funds: $13.1M → $7.38M (-$5.75M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 7

Holders
38
Holders Change
-7
Holders Change %
-15.56%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
9
Reduced
9
Closed
7
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$1K

Top Buyers

Rank Fund Capital Flow
1
P
Pfizer
New York
+$318K
2
CCC
Cable Car Capital
California
+$39.9K
3
Citigroup
Citigroup
New York
+$22.3K
4
Citadel Advisors
Citadel Advisors
Florida
+$8.79K
5
XT
XTX Topco
Cayman Islands
+$3.27K

Top Sellers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
-$217K
2
LFCM
Long Focus Capital Management
Puerto Rico
-$143K
3
BlackRock
BlackRock
New York
-$126K
4
PLC
Peapod Lane Capital
New York
-$102K
5
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$83K
Name Holding Trade Value Shares
Change 		Change in
Stake
IC
26
IEQ Capital
California
$17.9K – – –
VCIM
27
Velan Capital Investment Management
Georgia
$12K – – –
EGM
28
Engineers Gate Manager
New York
$9.7K – – –
SSA
29
Schonfeld Strategic Advisors
New York
$9.09K -$2.11K -239 -13%
XT
30
XTX Topco
Cayman Islands
$8.66K +$3.27K +371 +33%
HSBC Holdings
31
HSBC Holdings
United Kingdom
$8.45K -$79 -9 -0.6%
Millennium Management
32
Millennium Management
New York
$5.89K -$22.2K -2,520 -71%
Dimensional Fund Advisors
33
Dimensional Fund Advisors
Texas
$5.85K -$54.2K -6,139 -86%
UBS Group
34
UBS Group
Switzerland
$4.1K +$3.18K +361 +103%
TRCT
35
Tower Research Capital (TRC)
New York
$898 +$891 +101 +184%
JP Morgan Chase
36
JP Morgan Chase
New York
$387 – – –
BNP Paribas Financial Markets
37
BNP Paribas Financial Markets
France
$185 – – –
Bank of America
38
Bank of America
North Carolina
$126 +$9 +1 +5%
LFCM
39
Long Focus Capital Management
Puerto Rico
– -$143K -15,495 Closed
Hudson Bay Capital Management
40
Hudson Bay Capital Management
Connecticut
– -$83K -8,973 Closed
MAM
41
Marquette Asset Management
Minnesota
– -$44.9K -4,855 Closed
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
– -$37.2K -4,016 Closed
VF
43
Virtu Financial
New York
– -$18K -1,913 Closed
LPL Financial
44
LPL Financial
California
– -$15.8K -1,708 Closed
Osaic Holdings
45
Osaic Holdings
Arizona
– -$917 -99 Closed
Morgan Stanley
46
Morgan Stanley
New York
– -$1 – –
1
2

NXTC Hedge Fund Activity: Q1 2025 in Review

38 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q1 2025, worth a combined $7.38M — down 44% from $13.1M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of NXTC and 0 opened new positions — a net loss of 7 holders — while 9 trimmed existing stakes and 9 added.

The largest buyer was Pfizer, adding an estimated $318K. The largest seller was Tang Capital Management, cutting an estimated $217K.

  • 38 institutional investors held NextCure (NXTC) as of Q1 2025, down from 45 in Q4 2024.
  • Funds reported $7.38M of NextCure stock for Q1 2025, down 44% quarter-over-quarter.
  • 0 funds opened new NextCure positions in Q1 2025 and 7 closed out, a net change of -7 holders.
  • The largest NextCure buyer in Q1 2025 was Pfizer, an estimated $318K added.
  • The largest NextCure seller in Q1 2025 was Tang Capital Management, an estimated $217K sold.

Based on aggregated 13F filings for Q1 2025.